Document Detail


Acute pancreatitis associated with angiotensin II receptor antagonists.
MedLine Citation:
PMID:  12452749     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To report a case of acute pancreatitis in a patient receiving a combination formulation of irbesartan and hydrochlorothiazide (HCTZ). CASE SUMMARY: A 33-year-old white woman developed acute pancreatitis 10 days after starting irbesartan 300 mg and hydrochlorothiazide 12.5 mg for treatment of hypertension. Her symptoms disappeared and serum concentrations of lipase and amylase returned to normal 2 days after irbesartan/HCTZ was discontinued. A search of MEDLINE (1990-September 2002) and the Australian Adverse Drug Reaction Advisory Committee database revealed 1 additional case of pancreatitis associated with irbesartan/HCTZ and 3 cases of pancreatitis associated with losartan. DISCUSSION: An objective causality assessment indicates that it is probable that pancreatitis was caused by the angiotensin II receptor antagonist irbesartan (and the same is probably true for losartan). It is less likely that the hydrochlorothiazide in irbesartan/HCTZ caused pancreatitis in our patient since the dose was lower than that usually associated with thiazide-induced pancreatitis. Angiotensin II receptors are thought to be important in regulation of pancreatic secretion and microcirculation, but the mechanism of pancreatitis induced by angiotensin II receptor antagonists remains unclear. CONCLUSIONS: Clinicians should be aware that irbesartan/HCTZ or losartan may cause acute pancreatitis. If abdominal pain develops, the medication should be discontinued and the patient investigated for acute pancreatitis.
Authors:
Alexander A Fisher; Mark L Bassett
Related Documents :
21555059 - Sellar-suprasellar tuberculomas in children: 2 cases and literature review.
17147459 - Statins and pancreatitis: a systematic review of observational studies and spontaneous ...
8599159 - Delayed suprachoroidal hemorrhage mimicking acute retrobulbar hemorrhage.
9587259 - Acute gastroparesis in duchenne's muscular dystrophy.
16509919 - Acute laryngotracheobronchitis and associated transient hyperphosphatasemia: a new case...
2658729 - Acute and chronic toxic nephropathies.
12638849 - Wandering spleen presenting as a right hypochondrial mass and intestinal obstruction.
3942469 - Clostridium difficile-associated diarrhea and colitis in adults. a prospective case-con...
3139799 - Squamous cell carcinoma arising in an odontogenic cyst.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  36     ISSN:  1060-0280     ISO Abbreviation:  Ann Pharmacother     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-11-27     Completed Date:  2003-05-13     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1883-6     Citation Subset:  IM    
Affiliation:
Clinical Pharmacology and Toxicology, The Canberra Hospital, Woden, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Adult
Antihypertensive Agents / adverse effects*
Biphenyl Compounds / adverse effects*
Diuretics
Drug Combinations
Female
Humans
Hydrochlorothiazide / adverse effects*
Losartan / adverse effects
Pancreatitis / chemically induced*
Receptors, Angiotensin / antagonists & inhibitors*
Sodium Chloride Symporter Inhibitors / adverse effects
Tetrazoles / adverse effects*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Biphenyl Compounds; 0/Diuretics; 0/Drug Combinations; 0/Receptors, Angiotensin; 0/Sodium Chloride Symporter Inhibitors; 0/Tetrazoles; 114798-26-4/Losartan; 138402-11-6/irbesartan; 58-93-5/Hydrochlorothiazide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acitretin-associated thrombotic stroke.
Next Document:  Acute cholestatic hepatitis associated with celecoxib.